AN HLA CLASS II MATCHING STRATEGY USING SEROLOGY-DEFINED GROUPS PREDICTS DE NOVO DSA FORMATION BETTER THAN CONVENTIONAL HLA MISMATCHES

被引:0
|
作者
Hidalgo, L. G. [1 ,2 ]
Juarez, I. A. Martinez [3 ]
Campbell, P. [4 ]
机构
[1] Univ Wisconsin, Surg, Madison, WI USA
[2] Univ Wisconsin Hlth, Histocompatibil Lab, Madison, WI USA
[3] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Nephrol, Mexico City, Mexico
[4] Univ Alberta, HLA Lab, Edmonton, AB, Canada
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P64
引用
收藏
页码:108 / 109
页数:2
相关论文
共 6 条
  • [1] An HLA Class II Matching Strategy That Predicts De Novo Donor-specific HLA Antibody Formation Using Low Resolution HLA Types
    Hidalgo, L.
    Martinez Juarez, I.
    Morales Buenrostro, L.
    Shojai, S.
    Campbell, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 355 - 355
  • [2] HLA class II Eplet mismatch predicts De Novo DSA formation post lung transplant
    Walton, Duncan C.
    Cantwell, Linda
    Hiho, Steven
    Ta, Joseph
    Wright, Stephen
    Sullivan, Lucy C.
    Snell, Greg I.
    Westall, Glen P.
    TRANSPLANT IMMUNOLOGY, 2018, 51 : 73 - 75
  • [3] A Simple HLA Class II Matching Strategy for the Prediction of De Novo Donor-Specific HLA Antibodies
    Hidalgo, L. G.
    Juarez, I. A. Martinez
    Morales-Buenrostro, L.
    Shojai, S.
    Campbell, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 338 - 339
  • [4] HLA CLASS II EPLET MISMATCH PREDICTS DE NOVO DSA FORMATION AT 3 AND 12 MONTHS POST LUNG TRANSPLANT
    Walton, Duncan
    Hiho, Steven
    Cantwell, Linda
    Ta, Joseph
    Loskot, Monika
    Phan, Tracy
    Levvey, Bronwyn
    Snell, Greg
    Paraskeva, Miranda
    Westall, Glen
    HUMAN IMMUNOLOGY, 2017, 78 : 88 - 88
  • [5] Class I HLA Mismatches Increase Risk of Acute Rejection, Graft Loss and Formation of De Novo Class II Alloantibody
    Casey, E.
    Gandhi, M.
    Dean, P.
    Stegall, M.
    Cosio, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 42 - 42
  • [6] Class II HLA Epitope Matching-A Strategy to Minimize De Novo Donor-Specific Antibody Development and Improve Outcomes
    Wiebe, C.
    Pochinco, D.
    Blydt-Hansen, T. D.
    Ho, J.
    Birk, P. E.
    Karpinski, M.
    Goldberg, A.
    Storsley, L. J.
    Gibson, I. W.
    Rush, D. N.
    Nickerson, P. W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (12) : 3114 - 3122